OpenURL Connection Search

Select item for more details and to access through your institution.

Cardiovascular Safety of Anagrelide Hydrochloride versus Hydroxyurea in Essential Thrombocythaemia.
Published in:
Cardiovascular Toxicology, 2021, v. 21, n. 3, p. 236, doi. 10.1007/s12012-020-09615-0
By:
- Gotic, Mirjana;
- Egyed, Miklos;
- Gercheva, Liana;
- Warzocha, Krzysztof;
- Kvasnicka, Hans Michael;
- Achenbach, Heinrich;
- Wu, Jingyang
Publication type:
Article
Cardiac effects of deferasirox in transfusion‐dependent patients with myelodysplastic syndromes: TELESTO study.
Published in:
British Journal of Haematology, 2024, v. 204, n. 5, p. 2049, doi. 10.1111/bjh.19316
By:
- Sarocchi, Matteo;
- Li, Junmin;
- Li, Xiao;
- Wu, Depei;
- Montaño Figueroa, Efreen;
- Rodriguez, Maria Guadalupe;
- Hou, Ming;
- Finelli, Carlo;
- Shi, Hong‐Xia;
- Xiao, Zhijian;
- Oliva, Esther Natalie;
- Gercheva Kyuchukova, Liana;
- Drummond, Mark;
- Symeonidis, Argiris;
- Velazquez, Eric J.;
- Rivoli, Giulia;
- Izquierdo, Miguel;
- Kolekar, Yogita;
- Spallarossa, Paolo;
- Angelucci, Emanuele
Publication type:
Article
Rituximab maintenance overcomes the negative prognostic factor of obesity in CLL: Subgroup analysis of the international randomized AGMT CLL‐8a mabtenance trial.
Published in:
Cancer Medicine, 2019, v. 8, n. 4, p. 1401, doi. 10.1002/cam4.1980
By:
- Egle, Alexander;
- Melchardt, Thomas;
- Obrtlíková, Petra;
- Smolej, Lukáš;
- Kozák, Tomáš;
- Steurer, Michael;
- Andel, Johannes;
- Burgstaller, Sonja;
- Mikušková, Eva;
- Gercheva, Liana;
- Nösslinger, Thomas;
- Papajík, Tomáš;
- Ladická, Miriam;
- Girschikofsky, Michael;
- Hrubiško, Mikuláš;
- Jäger, Ulrich;
- Voskova, Daniela;
- Pecherstorfer, Martin;
- Králiková, Eva;
- Burcoveanu, Christina
Publication type:
Article
A phase 2, randomized, double-blind, placebo-controlled study of siltuximab (anti-IL-6 mAb) and bortezomib versus bortezomib alone in patients with relapsed or refractory multiple myeloma.
Published in:
American Journal of Hematology, 2015, v. 90, n. 1, p. 42, doi. 10.1002/ajh.23868
By:
- Orlowski, Robert Z.;
- Gercheva, Liana;
- Williams, Cathy;
- Sutherland, Heather;
- Robak, Tadeusz;
- Masszi, Tamás;
- Goranova-Marinova, Vesselina;
- Dimopoulos, Meletios A.;
- Cavenagh, James D.;
- Špička, Ivan;
- Maiolino, Angelo;
- Suvorov, Alexander;
- Bladé, Joan;
- Samoylova, Olga;
- Puchalski, Thomas A.;
- Reddy, Manjula;
- Bandekar, Rajesh;
- van de Velde, Helgi;
- Xie, Hong;
- Rossi, Jean-Franςois
Publication type:
Article
Bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukaemia: updated results of a randomized phase III trial.
Published in:
British Journal of Haematology, 2012, v. 159, n. 1, p. 67, doi. 10.1111/bjh.12000
By:
- Knauf, Wolfgang U.;
- Lissitchkov, Toshko;
- Aldaoud, Ali;
- Liberati, Anna M.;
- Loscertales, Javier;
- Herbrecht, Raoul;
- Juliusson, Gunnar;
- Postner, Gerhard;
- Gercheva, Liana;
- Goranov, Stefan;
- Becker, Martin;
- Fricke, Hans-Joerg;
- Huguet, Francoise;
- Del Giudice, Ilaria;
- Klein, Peter;
- Merkle, Karlheinz;
- Montillo, Marco
Publication type:
Article

Found: 5

Cardiovascular Safety of Anagrelide Hydrochloride versus Hydroxyurea in Essential Thrombocythaemia.

Cardiac effects of deferasirox in transfusion‐dependent patients with myelodysplastic syndromes: TELESTO study.

Rituximab maintenance overcomes the negative prognostic factor of obesity in CLL: Subgroup analysis of the international randomized AGMT CLL‐8a mabtenance trial.

A phase 2, randomized, double-blind, placebo-controlled study of siltuximab (anti-IL-6 mAb) and bortezomib versus bortezomib alone in patients with relapsed or refractory multiple myeloma.

Bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukaemia: updated results of a randomized phase III trial.